| KEZAR LIFE SCIENCES |
| USA |
| Gesundheit |
| US49372L2097 / A40NJT |
| 2KZ0 (Frankfurt) / KZR (NASDAQ) |
| FRA:2KZ0, ETR:2KZ0, 2KZ0:GR, NASDAQ:KZR |
| - |
| https://kezarlifesciences.. |
|
Kezar Life Sciences, Inc. is a biotechnology company focused on discovering and developing innovative therapies for serious diseases. The company specializes in immunology and oncology, aiming to address unmet medical needs through novel drug candida..
>Volltext.. |
| 39.46 Mio. EUR |
| -19.87 Mio. EUR |
| - |
| -44.64 Mio. EUR |
| -48.69 Mio. EUR |
| -6.66 EUR |
| 2.02 Mio. EUR |
| 62.46 Mio. EUR |
| -44.99 Mio. EUR |
| 10.93 |
| - |
| 41.02% |
| - |
| - |
| - |
| - |
| KEZAR LIFE |
| 30.03.26 |
|
||||
|